Xylo Technologies Ltd. Total Assets
Xylo Technologies Ltd. total assets. Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) holds total assets worth $37.55 Million USD as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see XYLO market cap overview for the company's overall valuation and market capitalisation.
Total Assets of Xylo Technologies Ltd. (2016–2024)
Total assets of Xylo Technologies Ltd. from 2016 to 2024. This chart illustrates how Xylo Technologies Ltd.'s total assets have evolved over time, based on quarterly financial data. See XYLO live share price for real-time trading data and today's change.
Xylo Technologies Ltd. - Asset Composition Analysis
Xylo Technologies Ltd. Total Assets Breakdown (December 2024)
Xylo Technologies Ltd. total assets breakdown as of December 2024. Xylo Technologies Ltd.'s total assets of $37.55 Million consist of 55.9% current assets and 44.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.3% |
| Accounts Receivable | $5.43 Million | 14.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $9.70 Million | 25.8% |
| Goodwill | $5.07 Million | 13.5% |
Asset Composition Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore XYLO working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Xylo Technologies Ltd.'s current assets represent 55.9% of total assets in 2024, a decrease from 75.9% in 2016.
- Cash Position: Cash and equivalents constituted 23.3% of total assets in 2024, down from 63.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 25.8% of total assets.
Xylo Technologies Ltd. Competitors by Total Assets
Key competitors of Xylo Technologies Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Xylo Technologies Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.14 | 1.08 | 2.46 |
| Quick Ratio | 1.14 | 1.00 | 2.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.56 Million | $2.40 Million | $4.91 Million |
Xylo Technologies Ltd. - Advanced Valuation Insights
This section examines the relationship between Xylo Technologies Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.36 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -41.2% |
| Total Assets | $37.55 Million |
| Market Capitalization | $6.49 Million USD |
Valuation Analysis
Below Book Valuation: The market values Xylo Technologies Ltd.'s assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Xylo Technologies Ltd.'s assets decreased by 41.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual total assets of Xylo Technologies Ltd. from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $37.55 Million | -41.23% |
| 2023-12-31 | $63.90 Million | -34.57% |
| 2022-12-31 | $97.65 Million | +63.49% |
| 2021-12-31 | $59.73 Million | +84.72% |
| 2020-12-31 | $32.34 Million | +142.50% |
| 2019-12-31 | $13.33 Million | +18.64% |
| 2018-12-31 | $11.24 Million | +55.88% |
| 2017-12-31 | $7.21 Million | +52.77% |
| 2016-12-31 | $4.72 Million | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more